{
  "docId": "019de074-1317-767b-825b-77b5f795fc6c",
  "docSlug": "27adacda91e6c92061c4de59bd9e9dc9",
  "documentTitle": "Theravance Biopharma | Investor Conference Presentation Deck | 44 slides",
  "authorId": "theravance-biopharma",
  "authorName": "Theravance Biopharma",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 33,
  "pageCount": 44,
  "prevPage": 32,
  "nextPage": 34,
  "slideType": "problem_statement",
  "function": "diagnose_problem",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide uses a biological mechanism diagram to illustrate the drug's effect on norepinephrine reuptake.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-1317-767b-825b-77b5f795fc6c/33",
  "deckHref": "/decks/019de074-1317-767b-825b-77b5f795fc6c",
  "deckJsonHref": "/decks/019de074-1317-767b-825b-77b5f795fc6c.json",
  "deckAnchorHref": "/decks/019de074-1317-767b-825b-77b5f795fc6c#slide-33",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.25,
        "x": 0.72,
        "y": 0.15
      },
      "kind": "image",
      "text": "Mechanism of action diagram showing NET inhibition by Ampreloxetine leading to vasoconstriction and reduced nOH symptoms.",
      "attrs": null,
      "subkind": "infographic",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "03a4bc61-e30b-4de3-89e2-4202bdb1a7ee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.65,
        "x": 0.04,
        "y": 0.0016
      },
      "kind": "list",
      "text": "nOH is a chronic, debilitating condition caused by autonomic dysfunction. nOH is present in ~80% of patients with MSA. Central autonomic lesions are predominant in MSA, while peripheral postganglionic fibers may remain intact.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0cb3cb49-e67b-48c8-95fe-a7d0230d4aa4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.6,
        "x": 0.08,
        "y": 0.46
      },
      "kind": "paragraph",
      "text": "Due to integrity of peripheral postganglionic fibers, patients with MSA may therefore be particularly well suited for NE reuptake inhibition treatment compared to patients with PD or PAF",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "29b957e7-04bd-45fd-bfc6-358402d018bf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.92,
        "x": 0.04,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "1. Kalra DK, et al. Clin Med Insights: Cardiol. 2020;14:1179546820953415. 2. Kaufmann H, et al. Clin Auton Res. 2021;31(6):699–711. MSA, multiple system atrophy; NE, norepinephrine; NET, norepinephrine transporter; nOH, neurogenic orthostatic hypotension; PAF, pure autonomic failure; PD, Parkinson's disease.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7763c1ab-c668-42bf-a906-e5c3c76879c8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.92,
        "x": 0.04,
        "y": 0.04
      },
      "kind": "title",
      "text": "Neurogenic Orthostatic Hypotension in MSA and Ampreloxetine",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "46ca6eeb-50f7-405e-a8ac-7974f7a72582",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "0c03698a-b334-4a50-a2f4-aba0b1bc608e",
      "evidence": "list/bullet: nOH is a chronic, debilitating condition caused by autonomic dysfunction.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}